Adam Irwin
Impact in
-
- Antibiotic Use and Resistance
- Nephrology top 5%
- Dialysis and Renal Disease Management
Papers in
-
- Antibiotic Use and Resistance 13
-
- Antibiotic Resistance in Bacteria 8
- Co-authors
- Tim MarshallStephen H. SmithJane A. LittleHugh C. RaynerMike SharlandPatrick N. A. HarrisEnitan D. CarrolM M Cotton
- Journals
- Archives of Disease in Childhood (5 papers)Current Infectious Disease Reports (3 papers)PEDIATRICS (3 papers)Journal of Antimicrobial Chemotherapy (3 papers)British Journal of Clinical Pharmacology (2 papers)
- Partner nations
- AustraliaUnited KingdomSwitzerland
In The Last Decade
Adam Irwin
57 papers receiving 906 citations
Peers
Comparison fields: 5 of 98
- Applied Microbiology and Biotechnology 121
- Nephrology 119
- Clinical Biochemistry 96
- Molecular Medicine 67
- Critical Care and Intensive Care Medicine 67
Countries citing papers authored by Adam Irwin
This map shows the geographic impact of Adam Irwin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Adam Irwin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Adam Irwin more than expected).
Fields of papers citing papers by Adam Irwin
This network shows the impact of papers produced by Adam Irwin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Adam Irwin. The network helps show where Adam Irwin may publish in the future.
Co-authors
The 25 scholars most cited alongside Adam Irwin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 0 | |
| 4 | 2024 | 1 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 15 | |
| 8 | 2024 | 8 | |
| 9 | 2024 | 9 | |
| 10 | 2023 | 8 | |
| 11 | 2023 | 0 | |
| 12 | 2023 | 3 | |
| 13 | 2022 | 7 | |
| 14 | 2022 | 1 | |
| 15 | 2021 | 26 | |
| 16 | 2021 | 24 | |
| 17 | 2017 | 11 | |
| 18 | 2016 | 13 | |
| 19 | 2015 | 1 | |
| 20 | Hospital at home services for acute exacerbation of chronic obstructive pulmonary disease: a survey of British practice. | 2001 | 15 |
About Adam Irwin
Adam Irwin is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine, Critical Care and Intensive Care Medicine, Clinical Biochemistry and Epidemiology, having authored 64 papers that have together received 934 indexed citations. Recurring topics across this work include Antibiotic Use and Resistance (13 papers), Sepsis Diagnosis and Treatment (12 papers), Pneumonia and Respiratory Infections (9 papers), Antibiotic Resistance in Bacteria (8 papers), Bacterial Identification and Susceptibility Testing (8 papers), Streptococcal Infections and Treatments (7 papers), Neonatal and Maternal Infections (7 papers) and Emergency and Acute Care Studies (7 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (121 citations), Nephrology (119 citations), Clinical Biochemistry (96 citations), Molecular Medicine (67 citations) and Critical Care and Intensive Care Medicine (67 citations). Adam Irwin has collaborated with scholars based in Australia, United Kingdom and Switzerland. Frequent co-authors include Tim Marshall, Stephen H. Smith, Jane A. Little, Hugh C. Rayner, Mike Sharland, Patrick N. A. Harris, Enitan D. Carrol, M M Cotton, OA Al-Rawas and Kirsty Le Doaré. Their work appears in journals such as Archives of Disease in Childhood, Current Infectious Disease Reports, PEDIATRICS, Journal of Antimicrobial Chemotherapy and British Journal of Clinical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.